Literature DB >> 718045

Pars plana vitrectomy in the management of blood-induced glaucoma with vitreous hemorrhage.

A J Brucker, R G Michels, W R Green.   

Abstract

Four consecutive cases are reported in which pars plana vitrectomy was used to treat eyes with blood-induced glaucoma complicating vitreous hemorrhage after cataract surgery. Vitrectomy resulted in removal of the posterior reservior of cells and cellular debris and cured the elevated intraocular pressure in 3 eyes. One eye required a second glaucoma procedure and long-term acetazolamide therapy. The excised vitreous was examined microscopically with several techniques, including use of a millipore filter to concentrate the cellular elements combined with a modified Papanicolaou staining technique, routine staining of sections of millipore filters, and routine staining of vitreous processed in a celloidin bag. These techniques showed variable proportions of erythrocytes, erythrocytic debris, free hemoglobin, ghost erythrocytes and macrophages containing erythrocytic debris and hemosiderin.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 718045

Source DB:  PubMed          Journal:  Ann Ophthalmol        ISSN: 0003-4886


  5 in total

Review 1.  Current management of vitreous hemorrhage due to proliferative diabetic retinopathy.

Authors:  Jaafar El Annan; Petros E Carvounis
Journal:  Int Ophthalmol Clin       Date:  2014

2.  Haemolytic glaucoma occurring in phakic eyes.

Authors:  A M Brooks; W E Gillies
Journal:  Br J Ophthalmol       Date:  1986-08       Impact factor: 4.638

3.  Pars plana vitrectomy in the management of ghost cell glaucoma.

Authors:  A M Abu el-Asrar; S A al-Obeidan
Journal:  Int Ophthalmol       Date:  1995       Impact factor: 2.031

4.  The Role of Head Elevation in Treatment of Vitreous Haemorrhage.

Authors:  Pear Pongsachareonnont; Nattadet Rattana-Aram; Thanapong Somkijrungroj
Journal:  Clin Ophthalmol       Date:  2020-01-07

Review 5.  Current management of diabetic tractional retinal detachments.

Authors:  Michael W Stewart; David J Browning; Maurice B Landers
Journal:  Indian J Ophthalmol       Date:  2018-12       Impact factor: 1.848

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.